Distinct subjects for predicate <http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/object> sorted by frequency

ResourceCount
alprazolam_bioavailability_continuous_value1
alprazolam_has_metabolite_4-hydroxyalprazolam1
alprazolam_has_metabolite_alpha-hydroxyalprazolam1
alprazolam_increases_auc_nefazodone1
alprazolam_increases_auc_selegiline1
alprazolam_is_not_substrate_of_cyp1a21
alprazolam_is_not_substrate_of_cyp3a41
alprazolam_is_not_substrate_of_cyp3a51
alprazolam_maximum_concentration_continuous_value1
alprazolam_primary_metabolic_clearance_enzyme_cyp3a41
alprazolam_primary_total_clearance_mechanism_Metabolic_Clearance1
alprazolam_substrate_of_cyp1a21
alprazolam_substrate_of_cyp3a41
alprazolam_substrate_of_cyp3a51
amiodarone_does_not_inhibit_cyp1a21
amiodarone_does_not_inhibit_cyp2c91
amiodarone_does_not_inhibit_cyp2d61
amiodarone_does_not_inhibit_cyp3a41
amiodarone_inhibits_cyp1a21
amiodarone_inhibits_cyp2c91
amiodarone_inhibits_cyp2d61
amiodarone_inhibits_cyp3a41
aripiprazole_bioavailability_continuous_value1
aripiprazole_does_not_inhibit_cyp1a21
aripiprazole_does_not_inhibit_cyp2c191
aripiprazole_does_not_inhibit_cyp2c91
aripiprazole_does_not_inhibit_cyp2d61
aripiprazole_does_not_inhibit_cyp3a41
aripiprazole_has_metabolite_dehydro-aripiprazole1
aripiprazole_increases_auc_escitalopram1
aripiprazole_increases_auc_venlafaxine1
aripiprazole_inhibits_cyp1a21
aripiprazole_inhibits_cyp2c191
aripiprazole_inhibits_cyp2c91
aripiprazole_inhibits_cyp2d61
aripiprazole_inhibits_cyp3a41
aripiprazole_is_not_substrate_of_cyp1a11
aripiprazole_is_not_substrate_of_cyp1a21
aripiprazole_is_not_substrate_of_cyp2a61
aripiprazole_is_not_substrate_of_cyp2b61
aripiprazole_is_not_substrate_of_cyp2c191
aripiprazole_is_not_substrate_of_cyp2c81
aripiprazole_is_not_substrate_of_cyp2c91
aripiprazole_is_not_substrate_of_cyp2d61
aripiprazole_is_not_substrate_of_cyp2e11
aripiprazole_is_not_substrate_of_cyp3a41
aripiprazole_maximum_concentration_continuous_value1
aripiprazole_primary_total_clearance_mechanism_Metabolic_Clearance1
aripiprazole_substrate_of_cyp1a11
aripiprazole_substrate_of_cyp1a21
aripiprazole_substrate_of_cyp2a61
aripiprazole_substrate_of_cyp2b61
aripiprazole_substrate_of_cyp2c191
aripiprazole_substrate_of_cyp2c81
aripiprazole_substrate_of_cyp2c91
aripiprazole_substrate_of_cyp2d61
aripiprazole_substrate_of_cyp2e11
aripiprazole_substrate_of_cyp3a41
atazanavir_does_not_inhibit_cyp1a21
atazanavir_does_not_inhibit_cyp2a61
atazanavir_does_not_inhibit_cyp2b61
atazanavir_does_not_inhibit_cyp2c191
atazanavir_does_not_inhibit_cyp2c91
atazanavir_does_not_inhibit_cyp2d61
atazanavir_does_not_inhibit_cyp2e11
atazanavir_does_not_inhibit_cyp3a41
atazanavir_does_not_inhibit_cyp3a51
atazanavir_inhibits_cyp1a21
atazanavir_inhibits_cyp2a61
atazanavir_inhibits_cyp2b61
atazanavir_inhibits_cyp2c191
atazanavir_inhibits_cyp2c91
atazanavir_inhibits_cyp2d61
atazanavir_inhibits_cyp2e11
atazanavir_inhibits_cyp3a41
atazanavir_inhibits_cyp3a51
atomoxetine_bioavailability_continuous_value1
atomoxetine_does_not_inhibit_cyp1a21
atomoxetine_does_not_inhibit_cyp2c91
atomoxetine_does_not_inhibit_cyp2d61
atomoxetine_has_metabolite_4-hydroxyatomoxetine1
atomoxetine_has_metabolite_N-desmethylatomoxetine1
atomoxetine_increases_auc_desipramine1
atomoxetine_inhibits_cyp1a21
atomoxetine_inhibits_cyp2c91
atomoxetine_inhibits_cyp2d61
atomoxetine_primary_total_clearance_enzyme_cyp2d61
atomoxetine_primary_total_clearance_mechanism_Metabolic_Clearance1
atorvastatin_bioavailability_continuous_value1
atorvastatin_does_not_inhibit_cyp3a41
atorvastatin_does_not_permanently_deactivate_catalytic_function_cyp2c81
atorvastatin_has_metabolite_ortho-hydroxy-atorvastatin1
atorvastatin_has_metabolite_para-hydroxy-atorvastatin1
atorvastatin_inhibition_constant_cyp2c81
atorvastatin_inhibits_cyp3a41
atorvastatin_is_not_substrate_of_cyp1a11
atorvastatin_is_not_substrate_of_cyp2b61
atorvastatin_is_not_substrate_of_cyp2c191
atorvastatin_is_not_substrate_of_cyp2c91
atorvastatin_is_not_substrate_of_cyp2d61
atorvastatin_is_not_substrate_of_cyp2e11
atorvastatin_is_not_substrate_of_cyp3a41
atorvastatin_is_not_substrate_of_cyp3a51
atorvastatin_maximum_concentration_continuous_value1
atorvastatin_primary_total_clearance_enzyme_cyp3a41
atorvastatin_primary_total_clearance_mechanism_Metabolic_Clearance1
atorvastatin_substrate_of_cyp1a11
atorvastatin_substrate_of_cyp2b61
atorvastatin_substrate_of_cyp2c191
atorvastatin_substrate_of_cyp2c91
atorvastatin_substrate_of_cyp2d61
atorvastatin_substrate_of_cyp2e11
atorvastatin_substrate_of_cyp3a41
atorvastatin_substrate_of_cyp3a51
bupropion_does_not_inhibit_cyp2d61
bupropion_has_metabolite_erythrohydrobupropion1
bupropion_has_metabolite_hydroxybupropion1
bupropion_has_metabolite_threohydrobupropion1
bupropion_increases_auc_desipramine1
bupropion_inhibits_cyp2d61
bupropion_is_not_substrate_of_cyp2b61
bupropion_maximum_concentration_continuous_value1
bupropion_primary_total_clearance_mechanism_Metabolic_Clearance1
bupropion_primary_total_clearance_mechanism_Renal_Excretion1
bupropion_substrate_of_cyp2b61
caffeine_primary_total_clearance_enzyme_cyp1a21
celecoxib_does_not_inhibit_cyp2c191
celecoxib_does_not_inhibit_cyp2c91
celecoxib_does_not_inhibit_cyp2d61
celecoxib_does_not_inhibit_cyp3a41
celecoxib_inhibits_cyp2c191
celecoxib_inhibits_cyp2c91
celecoxib_inhibits_cyp2d61
celecoxib_inhibits_cyp3a41
celecoxib_is_not_substrate_of_cyp2c91
celecoxib_maximum_concentration_continuous_value1
celecoxib_primary_total_clearance_mechanism_Metabolic_Clearance1
celecoxib_substrate_of_cyp2c91
chlorpromazine_bioavailability_continuous_value1
chlorpromazine_does_not_inhibit_cyp2c191
chlorpromazine_inhibits_cyp2c191
chlorpromazine_maximum_concentration_continuous_value1
chlorzoxazone_in_vitro_probe_substrate_of_enzyme_cyp2e11
cimetidine_does_not_inhibit_cyp1a21
cimetidine_does_not_inhibit_cyp3a41
cimetidine_does_not_inhibit_cyp3a51
cimetidine_increases_auc_amitriptyline1
cimetidine_increases_auc_citalopram1
cimetidine_increases_auc_doxepin1
cimetidine_increases_auc_erythrohydrobupropion1
cimetidine_increases_auc_escitalopram1
cimetidine_increases_auc_imipramine1
cimetidine_increases_auc_mirtazapine1
cimetidine_increases_auc_nefazodone1
cimetidine_increases_auc_nortriptyline1
cimetidine_increases_auc_paroxetine1
cimetidine_increases_auc_quetiapine1
cimetidine_increases_auc_sertraline1
cimetidine_increases_auc_theophylline1
cimetidine_increases_auc_threohydrobupropion1
cimetidine_increases_auc_venlafaxine1
cimetidine_increases_auc_ziprasidone1
cimetidine_inhibits_cyp1a21
cimetidine_inhibits_cyp3a41
cimetidine_inhibits_cyp3a51
cinacalcet_does_not_inhibit_cyp1a21
cinacalcet_does_not_inhibit_cyp2c191
cinacalcet_does_not_inhibit_cyp2c91
cinacalcet_does_not_inhibit_cyp2d61
cinacalcet_does_not_inhibit_cyp3a41
cinacalcet_does_not_inhibit_cyp3a51
cinacalcet_has_metabolite_hydrocinnamic-acid1
cinacalcet_has_metabolite_hydroxy-hydrocinnamic-acid1
cinacalcet_inhibits_cyp1a21
cinacalcet_inhibits_cyp2c191
cinacalcet_inhibits_cyp2c91
cinacalcet_inhibits_cyp2d61
cinacalcet_inhibits_cyp3a41
cinacalcet_inhibits_cyp3a51
cinacalcet_is_not_substrate_of_cyp1a21
cinacalcet_is_not_substrate_of_cyp2d61
cinacalcet_is_not_substrate_of_cyp3a41
cinacalcet_primary_total_clearance_mechanism_Metabolic_Clearance1
cinacalcet_substrate_of_cyp1a21
cinacalcet_substrate_of_cyp2d61
cinacalcet_substrate_of_cyp3a41
ciprofloxacin_does_not_inhibit_cyp1a21
ciprofloxacin_inhibits_cyp1a21
citalopram_bioavailability_continuous_value1
citalopram_does_not_inhibit_cyp2c91
citalopram_does_not_inhibit_cyp2e11
citalopram_does_not_inhibit_cyp3a41
citalopram_has_metabolite_demethylcitalopram1
citalopram_has_metabolite_didemethylcitalopram1
citalopram_increases_auc_alprazolam1
citalopram_increases_auc_desipramine1
citalopram_increases_auc_selegiline1
citalopram_inhibits_cyp1a21
citalopram_inhibits_cyp2c191
citalopram_inhibits_cyp2c91
citalopram_inhibits_cyp2d61
citalopram_inhibits_cyp2e11
citalopram_inhibits_cyp3a41
citalopram_is_not_substrate_of_cyp2c191
citalopram_is_not_substrate_of_cyp3a41
citalopram_primary_total_clearance_mechanism_Metabolic_Clearance1
citalopram_primary_total_clearance_mechanism_Renal_Excretion1
citalopram_substrate_of_cyp2c191
citalopram_substrate_of_cyp2d61
citalopram_substrate_of_cyp3a41
clarithromycin_bioavailability_continuous_value1
clarithromycin_does_not_inhibit_cyp3a41
clarithromycin_does_not_inhibit_cyp3a51
clarithromycin_does_not_permanently_deactivate_catalytic_function_cyp3a41
clarithromycin_fraction_absorbed_continuous_value1
clarithromycin_has_metabolite_14-hydroxyclarithromycin1
clarithromycin_in_viVo_selective_inhibitor_of_enzyme_cyp3a41
clarithromycin_increases_auc_atorvastatin1
clarithromycin_increases_auc_lansoprazole1
clarithromycin_increases_auc_midazolam1
clarithromycin_increases_auc_pravastatin1
clarithromycin_increases_auc_trazodone1
clarithromycin_increases_auc_triazolam1
clarithromycin_inhibition_constant_cyp3a41
clarithromycin_inhibits_cyp3a41
clarithromycin_inhibits_cyp3a51
clarithromycin_is_not_substrate_of_cyp1a21
clarithromycin_is_not_substrate_of_cyp2c91
clarithromycin_is_not_substrate_of_cyp2d61
clarithromycin_is_not_substrate_of_cyp3a41
clarithromycin_maximum_concentration_continuous_value1
clarithromycin_substrate_of_cyp1a21
clarithromycin_substrate_of_cyp2c91
clarithromycin_substrate_of_cyp2d61
clarithromycin_substrate_of_cyp3a41
clopidogrel_increases_auc_bupropion1
clopidogrel_inhibition_constant_cyp2b61
clozapine_does_not_inhibit_cyp2c191
clozapine_has_metabolite_7-hydroxyclozapine1
clozapine_has_metabolite_clozapine-N-oxide1
clozapine_has_metabolite_desmethylclozapine1
clozapine_inhibition_constant_cyp2c191
clozapine_inhibition_constant_cyp2c91
clozapine_inhibition_constant_cyp2d61
clozapine_inhibition_constant_cyp3a41
clozapine_inhibits_cyp2c191
clozapine_is_not_substrate_of_cyp1a21
clozapine_is_not_substrate_of_cyp2d61
clozapine_is_not_substrate_of_cyp3a41
clozapine_maximum_concentration_continuous_value1
clozapine_primary_total_clearance_mechanism_Metabolic_Clearance1
clozapine_substrate_of_cyp1a21
clozapine_substrate_of_cyp2d61
clozapine_substrate_of_cyp3a41
cyp1a1_controls_formation_of_threohydrobupropion1
cyp1a2_controls_formation_of_3-methylxanthine1
cyp1a2_controls_formation_of_4-(4-chlorophenyl)-4-hydroxypiperidine1
cyp1a2_controls_formation_of_N-dealkylperphenazine1
cyp1a2_controls_formation_of_O-desmethylvenlafaxine1
cyp1a2_controls_formation_of_hydroxybupropion1
cyp1a2_controls_formation_of_threohydrobupropion1
cyp1b1_controls_formation_of_threohydrobupropion1
cyp2a13_controls_formation_of_threohydrobupropion1
cyp2a6_controls_formation_of_threohydrobupropion1
cyp2b6_controls_formation_of_hydroxybupropion1
cyp2b6_controls_formation_of_threohydrobupropion1
cyp2c19_controls_formation_of_N-dealkylperphenazine1
cyp2c19_controls_formation_of_N-desmethylatomoxetine1
cyp2c19_controls_formation_of_N-desmethylsertraline1
cyp2c19_controls_formation_of_hydroxybupropion1
cyp2c19_controls_formation_of_threohydrobupropion1
cyp2c19_polymorphic_enzyme_True1
cyp2c8_controls_formation_of_6alpha-hydroxy-paclitaxel1
cyp2c8_controls_formation_of_N-dealkylperphenazine1
cyp2c8_controls_formation_of_threohydrobupropion1
cyp2c9_controls_formation_of_4-(4-chlorophenyl)-4-hydroxypiperidine1
cyp2c9_controls_formation_of_N-dealkylperphenazine1
cyp2c9_controls_formation_of_N-desmethylrosuvastatin1
cyp2c9_controls_formation_of_O-desmethylvenlafaxine1
cyp2c9_controls_formation_of_hydroxybupropion1
cyp2c9_controls_formation_of_threohydrobupropion1
cyp2c9_polymorphic_enzyme_True1
cyp2d6_controls_formation_of_4-(4-chlorophenyl)-4-hydroxypiperidine1
cyp2d6_controls_formation_of_4-hydroxyatomoxetine1
cyp2d6_controls_formation_of_4-hydroxydebrisoquine1
cyp2d6_controls_formation_of_9-hydroxyrisperidone1
cyp2d6_controls_formation_of_N-dealkylperphenazine1
cyp2d6_controls_formation_of_O-desmethylvenlafaxine1
cyp2d6_controls_formation_of_clozapine-N-oxide1
cyp2d6_controls_formation_of_desmethylclozapine1
cyp2d6_controls_formation_of_hydroxybupropion1
cyp2d6_controls_formation_of_threohydrobupropion1
cyp2d6_polymorphic_enzyme_True1
cyp2e1_controls_formation_of_1,3-dimethyluric-acid1
cyp2e1_controls_formation_of_N-dealkylperphenazine1
cyp2e1_controls_formation_of_threohydrobupropion1
cyp2j2_controls_formation_of_threohydrobupropion1
cyp3a4_controls_formation_of_1'-hydroxymidazolam1
cyp3a4_controls_formation_of_1,3-dimethyluric-acid1
cyp3a4_controls_formation_of_14-hydroxyclarithromycin1
cyp3a4_controls_formation_of_4-(4-chlorophenyl)-4-hydroxypiperidine1
cyp3a4_controls_formation_of_4-hydroxyalprazolam1
cyp3a4_controls_formation_of_4-hydroxymidazolam1
cyp3a4_controls_formation_of_6'beta-hydroxy-lovastatin1
cyp3a4_controls_formation_of_N-dealkylperphenazine1
cyp3a4_controls_formation_of_N-desmethyltamoxifen1
cyp3a4_controls_formation_of_N-desmethylvenlafaxine1
cyp3a4_controls_formation_of_alpha-hydroxyalprazolam1
cyp3a4_controls_formation_of_desmethylcitalopram1
cyp3a4_controls_formation_of_ortho-hydroxy-atorvastatin1
cyp3a4_controls_formation_of_para-hydroxy-atorvastatin1
cyp3a4_controls_formation_of_threohydrobupropion1
cyp3a4_controls_formation_of_ziprasidone-sulphoxide1
cyp3a4_polymorphic_enzyme_False1
cyp3a5_controls_formation_of_1'-hydroxymidazolam1
cyp3a5_controls_formation_of_4-hydroxyalprazolam1
cyp3a5_controls_formation_of_4-hydroxymidazolam1
cyp3a5_controls_formation_of_alpha-hydroxyalprazolam1
cyp3a5_controls_formation_of_ortho-hydroxy-atorvastatin1
cyp3a5_controls_formation_of_para-hydroxy-atorvastatin1
cyp3a5_controls_formation_of_threohydrobupropion1
cyp4a11_controls_formation_of_threohydrobupropion1
desipramine_increases_auc_nefazodone1
desipramine_primary_total_clearance_enzyme_cyp2d61
dextromethorphan_in_viVo_probe_substrate_of_enzyme_cyp2d61
dextromethorphan_in_vitro_probe_substrate_of_enzyme_cyp2d61
dextromethorphan_primary_total_clearance_enzyme_cyp2d61
diltiazem_bioavailability_continuous_value1
diltiazem_does_not_inhibit_cyp3a41
diltiazem_has_metabolite_N-demethyldesacetyl-diltiazem1
diltiazem_has_metabolite_N-demethyldiltiazem1
diltiazem_has_metabolite_desacetyldiltiazem1
diltiazem_increases_auc_beta-hydroxy-lovastatin1
diltiazem_increases_auc_imipramine1
diltiazem_increases_auc_midazolam1
diltiazem_increases_auc_pravastatin1
diltiazem_increases_auc_simvastatin1
diltiazem_increases_auc_triazolam1
diltiazem_inhibition_constant_cyp3a41
diltiazem_inhibits_cyp3a41
diltiazem_is_not_substrate_of_cyp3a41
diltiazem_is_not_substrate_of_cyp3a51
diltiazem_maximum_concentration_continuous_value1
diltiazem_permanently_deactivates_catalytic_function_cyp3a41
diltiazem_primary_metabolic_clearance_enzyme_cyp2d61
diltiazem_primary_total_clearance_mechanism_Metabolic_Clearance1
diltiazem_substrate_of_cyp3a41
diltiazem_substrate_of_cyp3a51
diphenhydramine_increases_auc_venlafaxine1
duloxetine_does_not_inhibit_cyp2c191
duloxetine_does_not_inhibit_cyp2c91
duloxetine_does_not_inhibit_cyp2d61
duloxetine_does_not_inhibit_cyp3a41
duloxetine_does_not_inhibit_cyp3a51
duloxetine_increases_auc_theophylline1
duloxetine_inhibits_cyp2c191
duloxetine_inhibits_cyp2c91
duloxetine_inhibits_cyp2d61
duloxetine_inhibits_cyp3a41
duloxetine_inhibits_cyp3a51
duloxetine_is_not_substrate_of_cyp1a21
duloxetine_is_not_substrate_of_cyp2d61
duloxetine_primary_total_clearance_mechanism_Metabolic_Clearance1
duloxetine_substrate_of_cyp1a21
duloxetine_substrate_of_cyp2d61
erythromycin_does_not_inhibit_cyp3a41
erythromycin_does_not_permanently_deactivate_catalytic_function_cyp3a41
erythromycin_in_viVo_selective_inhibitor_of_enzyme_cyp3a41
erythromycin_in_vitro_probe_substrate_of_enzyme_cyp3a41
erythromycin_in_vitro_selective_inhibitor_of_enzyme_cyp3a41
erythromycin_increases_auc_alprazolam1
erythromycin_increases_auc_atorvastatin1
erythromycin_increases_auc_beta-hydroxy-simvastatin1
erythromycin_increases_auc_fluvastatin1
erythromycin_increases_auc_midazolam1
erythromycin_increases_auc_quetiapine1
erythromycin_increases_auc_risperidone1
erythromycin_increases_auc_rosuvastatin1
erythromycin_increases_auc_simvastatin1
erythromycin_increases_auc_triazolam1
erythromycin_inhibition_constant_cyp3a41
erythromycin_inhibits_cyp3a41
escitalopram_bioavailability_continuous_value1
escitalopram_does_not_inhibit_cyp1a21
escitalopram_does_not_inhibit_cyp2c191
escitalopram_does_not_inhibit_cyp2c91
escitalopram_does_not_inhibit_cyp2d61
escitalopram_does_not_inhibit_cyp2e11
escitalopram_has_metabolite_S-demethylcitalopram1
escitalopram_has_metabolite_S-didemethylcitalopram1
escitalopram_inhibits_cyp1a21
escitalopram_inhibits_cyp2c191
escitalopram_inhibits_cyp2c91
escitalopram_inhibits_cyp2d61
escitalopram_inhibits_cyp2e11
escitalopram_inhibits_cyp3a41
escitalopram_is_not_substrate_of_cyp2c191
escitalopram_is_not_substrate_of_cyp2d61
escitalopram_is_not_substrate_of_cyp3a41
escitalopram_maximum_concentration_continuous_value1
escitalopram_primary_total_clearance_mechanism_Metabolic_Clearance1
escitalopram_primary_total_clearance_mechanism_Renal_Excretion1
escitalopram_substrate_of_cyp2c191
escitalopram_substrate_of_cyp2d61
escitalopram_substrate_of_cyp3a41
eszopiclone_does_not_inhibit_CYP1A21
eszopiclone_does_not_inhibit_CYP2A61
eszopiclone_does_not_inhibit_CYP2C191
eszopiclone_does_not_inhibit_CYP2C91
eszopiclone_does_not_inhibit_CYP2D61
eszopiclone_does_not_inhibit_CYP2E11
eszopiclone_does_not_inhibit_CYP3A41
eszopiclone_has_metabolite_S-N-desmethylzopiclone1
eszopiclone_has_metabolite_S-zopiclone-N-oxide1
eszopiclone_inhibits_CYP1A21
eszopiclone_inhibits_CYP2A61
eszopiclone_inhibits_CYP2C191
eszopiclone_inhibits_CYP2C91
eszopiclone_inhibits_CYP2D61
eszopiclone_inhibits_CYP2E11
eszopiclone_inhibits_CYP3A41
eszopiclone_is_not_substrate_of_cyp3a41
eszopiclone_primary_total_clearance_mechanism_Renal_Excretion1
eszopiclone_substrate_of_cyp2e11
eszopiclone_substrate_of_cyp3a41
fluconazole_bioavailability_continuous_value1
fluconazole_does_not_inhibit_cyp2c91
fluconazole_does_not_inhibit_cyp3a41
fluconazole_does_not_inhibit_cyp3a51
fluconazole_increases_auc_fluvastatin1
fluconazole_increases_auc_midazolam1
fluconazole_increases_auc_pravastatin1
fluconazole_increases_auc_rosuvastatin1
fluconazole_increases_auc_triazolam1
fluconazole_increases_auc_zolpidem1
fluconazole_inhibition_constant_cyp3a41
fluconazole_inhibits_cyp2c91
fluconazole_inhibits_cyp3a41
fluconazole_inhibits_cyp3a51
fluconazole_maximum_concentration_continuous_value1
fluconazole_primary_total_clearance_mechanism_Renal_Excretion1
fluoxetine_does_not_inhibit_cyp2d61
fluoxetine_has_metabolite_norfluoxetine1
fluoxetine_in_viVo_selective_inhibitor_of_enzyme_cyp2d61
fluoxetine_increases_auc_alprazolam1
fluoxetine_increases_auc_desipramine1
fluoxetine_increases_auc_imipramine1
fluoxetine_increases_auc_olanzapine1
fluoxetine_increases_auc_propafenone1
fluoxetine_inhibition_constant_cyp3a41
fluoxetine_inhibits_cyp2d61
fluoxetine_is_not_substrate_of_cyp2d61
fluoxetine_maximum_concentration_continuous_value1
fluoxetine_permanently_deactivates_catalytic_function_cyp2d61
fluoxetine_primary_total_clearance_mechanism_Metabolic_Clearance1
fluoxetine_substrate_of_cyp2d61
fluphenazine_bioavailability_continuous_value1
fluphenazine_does_not_inhibit_cyp2c191
fluphenazine_inhibition_constant_cyp1a21
fluphenazine_inhibition_constant_cyp2d61
fluphenazine_inhibits_cyp2c191
fluphenazine_maximum_concentration_continuous_value1
fluvastatin_bioavailability_continuous_value1
fluvastatin_does_not_permanently_deactivate_catalytic_function_cyp2c81
fluvastatin_inhibition_constant_cyp2c81
fluvastatin_is_not_substrate_of_cyp2c81
fluvastatin_is_not_substrate_of_cyp2c91
fluvastatin_is_not_substrate_of_cyp3a41
fluvastatin_maximum_concentration_continuous_value1
fluvastatin_primary_total_clearance_enzyme_cyp2c91
fluvastatin_primary_total_clearance_mechanism_Metabolic_Clearance1
fluvastatin_substrate_of_cyp2c81
fluvastatin_substrate_of_cyp2c91
fluvastatin_substrate_of_cyp3a41
fluvoxamine_bioavailability_continuous_value1
fluvoxamine_does_not_inhibit_cyp1a21
fluvoxamine_does_not_inhibit_cyp2c191
fluvoxamine_does_not_inhibit_cyp2c91
fluvoxamine_in_vitro_selective_inhibitor_of_enzyme_cyp1a21
fluvoxamine_increases_auc_amitriptyline1
fluvoxamine_increases_auc_clozapine1
fluvoxamine_increases_auc_duloxetine1
fluvoxamine_increases_auc_lansoprazole1
fluvoxamine_increases_auc_mexiletine1
fluvoxamine_increases_auc_omeprazole1
fluvoxamine_increases_auc_quinidine1
fluvoxamine_increases_auc_theophylline1
fluvoxamine_increases_auc_thioridazine1
fluvoxamine_increases_auc_tolbutamide1
fluvoxamine_inhibition_constant_cyp1a21
fluvoxamine_inhibits_cyp1a21
fluvoxamine_inhibits_cyp2c191
fluvoxamine_inhibits_cyp2c91
fluvoxamine_is_not_substrate_of_cyp2d61
fluvoxamine_primary_total_clearance_mechanism_Metabolic_Clearance1
fluvoxamine_substrate_of_cyp2d61
gemfibrozil_does_not_inhibit_cyp2c81
gemfibrozil_inhibits_cyp2c81
haloperidol_does_not_inhibit_cyp2c191
haloperidol_has_metabolite_4-(4-chlorophenyl)-4-hydroxypiperidine1
Skipped 69 rows
lansoprazole_is_not_substrate_of_cyp2c191
lansoprazole_is_not_substrate_of_cyp3a41
lansoprazole_is_not_substrate_of_cyp3a51
lansoprazole_maximum_concentration_continuous_value1
lansoprazole_primary_total_clearance_enzyme_cyp2c191
lansoprazole_primary_total_clearance_mechanism_Metabolic_Clearance1
lansoprazole_substrate_of_cyp2c191
lansoprazole_substrate_of_cyp3a41
lansoprazole_substrate_of_cyp3a51
leflunomide_has_metabolite_teriflunomide1
lovastatin_bioavailability_continuous_value1
lovastatin_does_not_permanently_deactivate_catalytic_function_cyp2c81
lovastatin_first_pass_effect_continuous_value1
lovastatin_has_metabolite_beta-hydroxy-lovastatin1
lovastatin_inhibition_constant_cyp2c81
lovastatin_is_not_substrate_of_cyp3a41
lovastatin_maximum_concentration_continuous_value1
lovastatin_primary_total_clearance_enzyme_cyp3a41
lovastatin_primary_total_clearance_mechanism_Metabolic_Clearance1
lovastatin_substrate_of_cyp3a41
mephenytoin_in_viVo_probe_substrate_of_enzyme_cyp2c191
metronidazole_maximum_concentration_continuous_value1
metronidazole_primary_total_clearance_mechanism_Renal_Excretion1
mexiletine_does_not_inhibit_cyp1a21
mexiletine_inhibits_cyp1a21
midazolam_has_metabolite_1'-hydroxymidazolam1
midazolam_has_metabolite_4-hydroxymidazolam1
midazolam_in_vitro_probe_substrate_of_enzyme_cyp3a41
midazolam_is_not_substrate_of_cyp3a51
midazolam_primary_total_clearance_enzyme_cyp3a41
midazolam_substrate_of_cyp3a51
midodrine_bioavailability_continuous_value1
midodrine_has_metabolite_desglymidodrine1
midodrine_primary_total_clearance_mechanism_Renal_Excretion1
mirtazapine_bioavailability_continuous_value1
mirtazapine_does_not_inhibit_cyp1a21
mirtazapine_does_not_inhibit_cyp2c191
mirtazapine_does_not_inhibit_cyp2c91
mirtazapine_does_not_inhibit_cyp2d61
mirtazapine_does_not_inhibit_cyp2e11
mirtazapine_fraction_absorbed_continuous_value1
mirtazapine_increases_auc_paroxetine1
mirtazapine_inhibits_cyp1a21
mirtazapine_inhibits_cyp2c191
mirtazapine_inhibits_cyp2c91
mirtazapine_inhibits_cyp2d61
mirtazapine_inhibits_cyp2e11
mirtazapine_is_not_substrate_of_cyp1a21
mirtazapine_is_not_substrate_of_cyp2a61
mirtazapine_is_not_substrate_of_cyp2b61
mirtazapine_is_not_substrate_of_cyp2c191
mirtazapine_is_not_substrate_of_cyp2d61
mirtazapine_is_not_substrate_of_cyp2e11
mirtazapine_is_not_substrate_of_cyp3a41
mirtazapine_is_not_substrate_of_cyp3a51
mirtazapine_substrate_of_cyp1a21
mirtazapine_substrate_of_cyp2a61
mirtazapine_substrate_of_cyp2b61
mirtazapine_substrate_of_cyp2c191
mirtazapine_substrate_of_cyp2d61
mirtazapine_substrate_of_cyp2e11
mirtazapine_substrate_of_cyp3a41
mirtazapine_substrate_of_cyp3a51
modafinil_does_not_inhibit_cyp2c191
modafinil_has_metabolite_modafinil-sulfone1
modafinil_inhibits_cyp2c191
modafinil_is_not_substrate_of_cyp3a41
modafinil_primary_total_clearance_mechanism_Metabolic_Clearance1
modafinil_substrate_of_cyp3a41
molindone_primary_total_clearance_mechanism_Metabolic_Clearance1
montelukast_does_not_inhibit_cyp1a21
montelukast_does_not_inhibit_cyp2a61
montelukast_does_not_inhibit_cyp2c191
montelukast_does_not_inhibit_cyp2c81
montelukast_does_not_inhibit_cyp2c91
montelukast_does_not_inhibit_cyp2d61
montelukast_does_not_inhibit_cyp3a41
montelukast_inhibition_constant_cyp2c81
montelukast_inhibits_cyp1a21
montelukast_inhibits_cyp2a61
montelukast_inhibits_cyp2c191
montelukast_inhibits_cyp2c81
montelukast_inhibits_cyp2c91
montelukast_inhibits_cyp2d61
montelukast_inhibits_cyp3a41
nefazodone_does_not_inhibit_cyp1a21
nefazodone_does_not_inhibit_cyp3a41
nefazodone_does_not_inhibit_cyp3a51
nefazodone_in_viVo_selective_inhibitor_of_enzyme_cyp3a41
nefazodone_increases_auc_alprazolam1
nefazodone_increases_auc_midazolam1
nefazodone_increases_auc_triazolam1
nefazodone_inhibits_cyp1a21
nefazodone_inhibits_cyp3a41
nefazodone_inhibits_cyp3a51
nefazodone_is_not_substrate_of_cyp1a21
nefazodone_is_not_substrate_of_cyp2c191
nefazodone_is_not_substrate_of_cyp2c81
nefazodone_is_not_substrate_of_cyp2c91
nefazodone_is_not_substrate_of_cyp2d61
nefazodone_is_not_substrate_of_cyp3a41
nefazodone_substrate_of_cyp1a21
nefazodone_substrate_of_cyp2c191
nefazodone_substrate_of_cyp2c81
nefazodone_substrate_of_cyp2c91
nefazodone_substrate_of_cyp2d61
nefazodone_substrate_of_cyp3a41
nicardipine_bioavailability_continuous_value1
norfloxacin_does_not_inhibit_cyp1a21
norfloxacin_inhibits_cyp1a21
olanzapine_has_metabolite_10-N-glucuronide1
olanzapine_increases_auc_selegiline1
olanzapine_inhibition_constant_cyp2c191
olanzapine_inhibition_constant_cyp2c91
olanzapine_inhibition_constant_cyp3a41
olanzapine_is_not_substrate_of_cyp2d61
olanzapine_maximum_concentration_continuous_value1
olanzapine_primary_total_clearance_mechanism_Metabolic_Clearance1
olanzapine_primary_total_clearance_mechanism_Renal_Excretion1
olanzapine_substrate_of_cyp2d61
omeprazole_does_not_inhibit_cyp2c191
omeprazole_does_not_inhibit_cyp2d61
omeprazole_in_vitro_probe_substrate_of_enzyme_cyp2c191
omeprazole_in_vitro_selective_inhibitor_of_enzyme_cyp2c191
omeprazole_increases_auc_escitalopram1
omeprazole_inhibits_cyp2c191
omeprazole_inhibits_cyp2d61
omeprazole_primary_total_clearance_enzyme_cyp2c191
paclitaxel_has_metabolite_6alpha-hydroxy-paclitaxel1
paclitaxel_in_vitro_probe_substrate_of_enzyme_cyp2c81
paliperidone_bioavailability_continuous_value1
paliperidone_does_not_inhibit_cyp1a21
paliperidone_does_not_inhibit_cyp2a61
paliperidone_does_not_inhibit_cyp2c191
paliperidone_does_not_inhibit_cyp2c81
paliperidone_does_not_inhibit_cyp2c91
paliperidone_does_not_inhibit_cyp2d61
paliperidone_does_not_inhibit_cyp2e11
paliperidone_does_not_inhibit_cyp3a41
paliperidone_does_not_inhibit_cyp3a51
paliperidone_inhibition_constant_cyp2d61
paliperidone_inhibits_cyp1a21
paliperidone_inhibits_cyp2a61
paliperidone_inhibits_cyp2c191
paliperidone_inhibits_cyp2c81
paliperidone_inhibits_cyp2c91
paliperidone_inhibits_cyp2d61
paliperidone_inhibits_cyp2e11
paliperidone_inhibits_cyp3a41
paliperidone_inhibits_cyp3a51
paliperidone_primary_total_clearance_mechanism_Renal_Excretion1
pantoprazole_bioavailability_continuous_value1
pantoprazole_does_not_inhibit_cyp2d61
pantoprazole_inhibits_cyp2d61
pantoprazole_is_not_substrate_of_cyp2c191
pantoprazole_is_not_substrate_of_cyp3a41
pantoprazole_maximum_concentration_continuous_value1
pantoprazole_primary_total_clearance_enzyme_cyp2c191
pantoprazole_primary_total_clearance_mechanism_Metabolic_Clearance1
pantoprazole_primary_total_clearance_mechanism_Renal_Excretion1
pantoprazole_substrate_of_cyp2c191
pantoprazole_substrate_of_cyp3a41
paroxetine_does_not_inhibit_cyp2d61
paroxetine_in_viVo_selective_inhibitor_of_enzyme_cyp2d61
paroxetine_in_vitro_selective_inhibitor_of_enzyme_cyp2d61
paroxetine_increases_auc_desipramine1
paroxetine_increases_auc_duloxetine1
paroxetine_increases_auc_imipramine1
paroxetine_increases_auc_mirtazapine1
paroxetine_increases_auc_nortriptyline1
paroxetine_increases_auc_paliperidone1
paroxetine_increases_auc_risperidone1
paroxetine_inhibits_cyp2d61
paroxetine_is_not_substrate_of_cyp2d61
paroxetine_permanently_deactivates_catalytic_function_cyp2d61
paroxetine_primary_total_clearance_mechanism_Metabolic_Clearance1
paroxetine_substrate_of_cyp2d61
perphenazine_does_not_inhibit_cyp2c191
perphenazine_has_metabolite_7-hydroxyperphenazine1
perphenazine_inhibition_constant_cyp1a21
perphenazine_inhibition_constant_cyp2d61
perphenazine_inhibits_cyp2c191
perphenazine_is_not_substrate_of_cyp1a21
perphenazine_is_not_substrate_of_cyp2c191
perphenazine_is_not_substrate_of_cyp2d61
perphenazine_is_not_substrate_of_cyp3a41
perphenazine_maximum_concentration_continuous_value1
perphenazine_primary_total_clearance_mechanism_Metabolic_Clearance1
perphenazine_substrate_of_cyp1a21
perphenazine_substrate_of_cyp2c191
perphenazine_substrate_of_cyp2d61
perphenazine_substrate_of_cyp3a41
phenacetin_in_vitro_probe_substrate_of_enzyme_cyp1a21
pioglitazone_inhibition_constant_cyp2c81
pravastatin_does_not_inhibit_cyp2c81
pravastatin_has_metabolite_3alpha-hydroxypravastatin1
pravastatin_inhibits_cyp2c81
pravastatin_primary_total_clearance_mechanism_Renal_Excretion1
propafenone_does_not_inhibit_cyp1a21
propafenone_inhibits_cyp1a21
propoxyphene_has_metabolite_norpropoxyphene1
quetiapine_does_not_inhibit_cyp1a21
quetiapine_does_not_inhibit_cyp2c191
quetiapine_does_not_inhibit_cyp2c91
quetiapine_does_not_inhibit_cyp2d61
quetiapine_does_not_inhibit_cyp3a41
quetiapine_has_metabolite_7-hydroxy-N-desalkyl-quetiapine1
quetiapine_has_metabolite_7-hydroxy-quetiapine1
quetiapine_has_metabolite_N-desalkylquetiapine1
quetiapine_has_metabolite_quetiapine-sulfoxide1
quetiapine_inhibits_cyp1a21
quetiapine_inhibits_cyp2c191
quetiapine_inhibits_cyp2c91
quetiapine_inhibits_cyp2d61
quetiapine_inhibits_cyp3a41
quetiapine_is_not_substrate_of_cyp1a21
quetiapine_is_not_substrate_of_cyp2c191
quetiapine_is_not_substrate_of_cyp2c91
quetiapine_is_not_substrate_of_cyp2e11
quetiapine_is_not_substrate_of_cyp3a41
quetiapine_primary_total_clearance_mechanism_Metabolic_Clearance1
quetiapine_substrate_of_cyp1a21
quetiapine_substrate_of_cyp2c191
quetiapine_substrate_of_cyp2c91
quetiapine_substrate_of_cyp2e11
quetiapine_substrate_of_cyp3a41
quinidine_does_not_inhibit_cyp2d61
quinidine_in_viVo_selective_inhibitor_of_enzyme_cyp2d61
quinidine_in_vitro_selective_inhibitor_of_enzyme_cyp2d61
quinidine_increases_auc_venlafaxine1
quinidine_inhibits_cyp2d61
quinidine_permanently_deactivates_catalytic_function_cyp2d61
rabeprazole_bioavailability_continuous_value1
rabeprazole_is_not_substrate_of_cyp2c191
rabeprazole_is_not_substrate_of_cyp3a41
rabeprazole_is_not_substrate_of_cyp3a51
rabeprazole_primary_total_clearance_mechanism_Metabolic_Clearance1
rabeprazole_substrate_of_cyp2c191
rabeprazole_substrate_of_cyp3a41
rabeprazole_substrate_of_cyp3a51
ranolazine_does_not_inhibit_cyp2d61
ranolazine_does_not_inhibit_cyp3a41
ranolazine_does_not_inhibit_cyp3a51
ranolazine_inhibits_cyp2d61
ranolazine_inhibits_cyp3a41
ranolazine_inhibits_cyp3a51
ranolazine_is_not_substrate_of_cyp2d61
ranolazine_maximum_concentration_continuous_value1
ranolazine_primary_total_clearance_enzyme_cyp3a41
ranolazine_primary_total_clearance_mechanism_Metabolic_Clearance1
ranolazine_substrate_of_cyp2d61
risperidone_bioavailability_continuous_value1
risperidone_does_not_inhibit_cyp2c191
risperidone_has_metabolite_9-hydroxyrisperidone1
risperidone_increases_auc_erythromycin1
risperidone_increases_auc_quetiapine1
risperidone_increases_auc_selegiline1
risperidone_inhibition_constant_cyp2d61
risperidone_inhibits_cyp2c191
risperidone_is_not_substrate_of_cyp2d61
risperidone_is_not_substrate_of_cyp3a41
risperidone_maximum_concentration_continuous_value1
risperidone_primary_metabolic_clearance_enzyme_cyp2d61
risperidone_primary_total_clearance_mechanism_Metabolic_Clearance1
risperidone_substrate_of_cyp2d61
risperidone_substrate_of_cyp3a41
ritonavir_does_not_inhibit_cyp2d61
ritonavir_does_not_inhibit_cyp3a41
ritonavir_does_not_inhibit_cyp3a51
ritonavir_increases_auc_bupropion1
ritonavir_increases_auc_trazodone1
ritonavir_inhibits_cyp2d61
ritonavir_inhibits_cyp3a41
ritonavir_inhibits_cyp3a51
rosiglitazone_does_not_inhibit_cyp1a11
rosiglitazone_does_not_inhibit_cyp1a21
rosiglitazone_does_not_inhibit_cyp2a61
rosiglitazone_does_not_inhibit_cyp2b61
rosiglitazone_does_not_inhibit_cyp2c191
rosiglitazone_does_not_inhibit_cyp2c81
rosiglitazone_does_not_inhibit_cyp2c91
rosiglitazone_does_not_inhibit_cyp2d61
rosiglitazone_does_not_inhibit_cyp2e11
rosiglitazone_does_not_inhibit_cyp3a41
rosiglitazone_does_not_inhibit_cyp3a51
rosiglitazone_inhibition_constant_cyp2c81
rosiglitazone_inhibits_cyp1a11
rosiglitazone_inhibits_cyp1a21
rosiglitazone_inhibits_cyp2a61
rosiglitazone_inhibits_cyp2b61
rosiglitazone_inhibits_cyp2c191
rosiglitazone_inhibits_cyp2c81
rosiglitazone_inhibits_cyp2c91
rosiglitazone_inhibits_cyp2d61
rosiglitazone_inhibits_cyp2e11
rosiglitazone_inhibits_cyp3a41
rosiglitazone_inhibits_cyp3a51
rosiglitazone_primary_total_clearance_enzyme_cyp2c81
rosuvastatin_bioavailability_continuous_value1
rosuvastatin_does_not_inhibit_cyp2c81
rosuvastatin_fraction_absorbed_continuous_value1
rosuvastatin_has_metabolite_N-desmethylrosuvastatin1
rosuvastatin_inhibits_cyp2c81
rosuvastatin_is_not_substrate_of_cyp3a41
rosuvastatin_maximum_concentration_continuous_value1
rosuvastatin_primary_metabolic_clearance_enzyme_cyp2c91
rosuvastatin_primary_total_clearance_mechanism_Biliary_Excretion1
rosuvastatin_substrate_of_cyp3a41
sertraline_does_not_inhibit_cyp2d61
sertraline_has_metabolite_N-desmethylsertraline1
sertraline_increases_auc_alprazolam1
sertraline_increases_auc_clozapine1
sertraline_increases_auc_clozapine-N-oxide1
sertraline_increases_auc_desipramine1
sertraline_increases_auc_desmethylclozapine1
sertraline_increases_auc_zolpidem1
sertraline_inhibits_cyp2d61
sertraline_is_not_substrate_of_cyp2c191
sertraline_substrate_of_cyp2c191
sildenafil_primary_total_clearance_enzyme_cyp3a41
simvastatin_does_not_inhibit_cyp3a41
simvastatin_does_not_permanently_deactivate_catalytic_function_cyp2c81
simvastatin_has_metabolite_beta-hydroxy-simvastatin1
simvastatin_inhibition_constant_cyp2c81
simvastatin_inhibits_cyp3a41
simvastatin_is_not_substrate_of_cyp3a41
simvastatin_primary_total_clearance_enzyme_cyp3a41
simvastatin_primary_total_clearance_mechanism_Metabolic_Clearance1
simvastatin_substrate_of_cyp3a41
sulfinpyrazone_in_vitro_selective_inhibitor_of_enzyme_cyp2c91
tamoxifen_has_metabolite_4-hydroxytamoxifin1
tamoxifen_has_metabolite_N-desmethyltamoxifen1
tamoxifen_is_not_substrate_of_cyp2c91
tamoxifen_is_not_substrate_of_cyp2d61
tamoxifen_is_not_substrate_of_cyp3a41
tamoxifen_is_not_substrate_of_cyp3a51
tamoxifen_primary_total_clearance_mechanism_Metabolic_Clearance1
tamoxifen_substrate_of_cyp2c91
tamoxifen_substrate_of_cyp2d61
tamoxifen_substrate_of_cyp3a41
tamoxifen_substrate_of_cyp3a51
telithromycin_does_not_inhibit_cyp3a41
telithromycin_does_not_inhibit_cyp3a51
telithromycin_inhibits_cyp3a41
telithromycin_inhibits_cyp3a51
terbinafine_does_not_inhibit_cyp2d61
terbinafine_increases_auc_paroxetine1
terbinafine_increases_auc_venlafaxine1
terbinafine_inhibits_cyp2d61
testosterone_in_vitro_probe_substrate_of_enzyme_cyp3a41
theophylline_has_metabolite_1,3-dimethyluric-acid1
theophylline_has_metabolite_1-methylxanthine1
theophylline_has_metabolite_3-methylxanthine1
theophylline_has_metabolite_caffeine1
theophylline_in_vitro_probe_substrate_of_enzyme_cyp1a21
theophylline_primary_total_clearance_enzyme_cyp1a21
theophylline_primary_total_clearance_mechanism_Metabolic_Clearance1
thioridazine_does_not_inhibit_cyp2c191
thioridazine_has_metabolite_mesoridazine1
thioridazine_has_metabolite_sulforidazine1
thioridazine_has_metabolite_thioridazine-5-sulfoxide1
thioridazine_inhibition_constant_cyp2d61
thioridazine_inhibits_cyp2c191
thioridazine_is_not_substrate_of_cyp2d61
thioridazine_primary_total_clearance_enzyme_cyp2d61
thioridazine_substrate_of_cyp2d61
thiothixene_does_not_inhibit_cyp2c191
thiothixene_inhibition_constant_cyp2d61
thiothixene_inhibits_cyp2c191
ticlopidine_increases_auc_bupropion1
ticlopidine_inhibition_constant_cyp2b61
ticlopidine_inhibition_constant_cyp2c191
tolbutamide_in_vitro_probe_substrate_of_enzyme_cyp2c91
tolbutamide_primary_total_clearance_enzyme_cyp2c91
topiramate_does_not_inhibit_cyp1a21
topiramate_does_not_inhibit_cyp2a61
topiramate_does_not_inhibit_cyp2b61
topiramate_does_not_inhibit_cyp2c191
topiramate_does_not_inhibit_cyp2c91
topiramate_does_not_inhibit_cyp2d61
topiramate_does_not_inhibit_cyp2e11
topiramate_does_not_inhibit_cyp3a41
topiramate_does_not_inhibit_cyp3a51
topiramate_inhibits_cyp1a21
topiramate_inhibits_cyp2a61
topiramate_inhibits_cyp2b61
topiramate_inhibits_cyp2c191
topiramate_inhibits_cyp2c91
topiramate_inhibits_cyp2d61
topiramate_inhibits_cyp2e11
topiramate_inhibits_cyp3a41
topiramate_inhibits_cyp3a51
topiramate_primary_total_clearance_mechanism_Renal_Excretion1
trazodone_bioavailability_continuous_value1
trazodone_has_metabolite_M-chlorophenylpiperazine1
trazodone_is_not_substrate_of_cyp3a41
trazodone_maximum_concentration_continuous_value1
trazodone_primary_total_clearance_mechanism_Renal_Excretion1
trazodone_substrate_of_cyp3a41
triazolam_in_vitro_probe_substrate_of_enzyme_cyp3a41
triazolam_increases_auc_nefazodone1
triazolam_primary_total_clearance_enzyme_cyp3a41
trimethoprim_does_not_inhibit_cyp2c81
trimethoprim_inhibits_cyp2c81
troleandomycin_in_vitro_selective_inhibitor_of_enzyme_cyp3a41
venlafaxine_does_not_inhibit_cyp1a21
venlafaxine_does_not_inhibit_cyp2c91
venlafaxine_does_not_inhibit_cyp2d61
venlafaxine_does_not_inhibit_cyp3a41
venlafaxine_fraction_absorbed_continuous_value1
venlafaxine_has_metabolite_N-desmethylvenlafaxine1
venlafaxine_has_metabolite_O-desmethylvenlafaxine1
venlafaxine_increases_auc_9-hydroxyrisperidone1
venlafaxine_increases_auc_alprazolam1
venlafaxine_increases_auc_desipramine1
venlafaxine_increases_auc_haloperidol1
venlafaxine_increases_auc_imipramine1
venlafaxine_increases_auc_risperidone1
venlafaxine_inhibits_cyp1a21
venlafaxine_inhibits_cyp2c91
venlafaxine_inhibits_cyp2d61
venlafaxine_inhibits_cyp3a41
venlafaxine_is_not_substrate_of_cyp2d61
venlafaxine_is_not_substrate_of_cyp3a41
venlafaxine_maximum_concentration_continuous_value1
venlafaxine_primary_total_clearance_enzyme_cyp2d61
venlafaxine_primary_total_clearance_mechanism_Metabolic_Clearance1
venlafaxine_substrate_of_cyp2d61
venlafaxine_substrate_of_cyp3a41
verapamil_does_not_inhibit_cyp1a21
verapamil_does_not_inhibit_cyp3a41
verapamil_does_not_inhibit_cyp3a51
verapamil_increases_auc_imipramine1
verapamil_increases_auc_risperidone1
verapamil_inhibits_cyp1a21
verapamil_inhibits_cyp3a41
verapamil_inhibits_cyp3a51
voriconazole_bioavailability_continuous_value1
voriconazole_does_not_inhibit_cyp2c191
voriconazole_does_not_inhibit_cyp2c91
voriconazole_does_not_inhibit_cyp3a41
voriconazole_has_metabolite_voriconazole-N-oxide1
voriconazole_inhibits_cyp2c191
voriconazole_inhibits_cyp2c91
voriconazole_inhibits_cyp3a41
voriconazole_is_not_substrate_of_cyp2c191
voriconazole_is_not_substrate_of_cyp2c91
voriconazole_is_not_substrate_of_cyp3a41
voriconazole_maximum_concentration_continuous_value1
voriconazole_primary_total_clearance_enzyme_cyp2c191
voriconazole_primary_total_clearance_mechanism_Metabolic_Clearance1
voriconazole_substrate_of_cyp2c191
voriconazole_substrate_of_cyp2c91
voriconazole_substrate_of_cyp3a41
warfarin_primary_total_clearance_enzyme_cyp2c91
zafirlukast_does_not_inhibit_cyp2c91
zafirlukast_does_not_inhibit_cyp3a41
zafirlukast_inhibits_cyp2c91
zafirlukast_inhibits_cyp3a41
zafirlukast_is_not_substrate_of_cyp2c91
zafirlukast_maximum_concentration_continuous_value1
zafirlukast_substrate_of_cyp2c91
zaleplon_bioavailability_continuous_value1
zaleplon_is_not_substrate_of_cyp2d61
zaleplon_is_not_substrate_of_cyp3a41
zaleplon_primary_total_clearance_mechanism_Metabolic_Clearance1
zaleplon_substrate_of_cyp2d61
zaleplon_substrate_of_cyp3a41
ziprasidone_does_not_inhibit_cyp1a21
ziprasidone_does_not_inhibit_cyp2c191
ziprasidone_does_not_inhibit_cyp2c91
ziprasidone_does_not_inhibit_cyp2d61
ziprasidone_does_not_inhibit_cyp3a41
ziprasidone_has_metabolite_S-methyl-dihydroziprasidone1
ziprasidone_has_metabolite_benzisothiazole-sulphone1
ziprasidone_has_metabolite_benzisothiazole-sulphoxide1
ziprasidone_has_metabolite_ziprasidone-sulphoxide1
ziprasidone_inhibition_constant_cyp2d61
ziprasidone_inhibits_cyp1a21
ziprasidone_inhibits_cyp2c191
ziprasidone_inhibits_cyp2c91
ziprasidone_inhibits_cyp2d61
ziprasidone_inhibits_cyp3a41
ziprasidone_is_not_substrate_of_cyp1a21
ziprasidone_is_not_substrate_of_cyp2c191
ziprasidone_is_not_substrate_of_cyp2c91
ziprasidone_is_not_substrate_of_cyp2d61
ziprasidone_is_not_substrate_of_cyp3a41
ziprasidone_maximum_concentration_continuous_value1
ziprasidone_primary_total_clearance_mechanism_Metabolic_Clearance1
ziprasidone_substrate_of_cyp1a21
ziprasidone_substrate_of_cyp2c191
ziprasidone_substrate_of_cyp2c91
ziprasidone_substrate_of_cyp2d61
ziprasidone_substrate_of_cyp3a41
zolpidem_is_not_substrate_of_cyp3a41
zolpidem_is_not_substrate_of_cyp3a51
zolpidem_maximum_concentration_continuous_value1
zolpidem_substrate_of_cyp3a41
zolpidem_substrate_of_cyp3a51